Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK14 | Q16539 | 3/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 9/20 | 0.44 |
| ▸ | HSPB1 | P04792 | 1/20 | 0.42 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 3/20 | 0.40 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5206393 | 0.86 | MEN1 (0.39) | — | |
| SCHEMBL7712456 | 0.81 | MEN1 (0.44) | TRPA1HSPB1 | |
| SCHEMBL7714596 | 0.80 | XDH (0.42) | TRPA1 | |
| SCHEMBL7712364 | 0.79 | USP2 (0.45) | MAP4K4 | |
| SCHEMBL5204487 | 0.77 | SOS1 (0.40) | TRPA1MAP4K4 | |
| SCHEMBL5206842 | 0.74 | MEN1 (0.53) | — | |
| SCHEMBL7712418 | 0.74 | SMN1; SMN2 (0.41) | MAP4K4 | |
| SCHEMBL7712415 | 0.74 | ALDH1A1 (0.41) | MAP4K4 | |
| SCHEMBL21634034 | 0.74 | EPAS1 (0.47) | MAPK14TRPA1HSPB1MAP4K4EPAS1 | |
| SCHEMBL7714270 | 0.72 | CYP1A2 (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1165523-B1 | NEUROTROPHIC SUBSTITUTED PYRIMIDINES | KRENITSKY PHARMACEUTICALS INC (US) | 2007-11-07 | — | — | EP | disclosed |
| US-6916820-B1 | Neurotrophic substituted pyrimidines | KRENITSKY PHARMACEUTICALS, INC. (US) | 2005-07-12 | — | — | US | disclosed |
| US-6583148-B1 | Neurodegenerative or other neurological disorders; enhancing the effect of nerve growth factor; 2-Amino-5-(4-chlorophenoxy)-4-trans-4-hydroxycyclohexylamino) pyrimidine | KRENITSKY PHARMACEUTICALS, INC. | 2003-06-24 | — | — | US | disclosed |
| US-6440965-B1 | Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system | KRENITSKY PHARMACEUTICALS, INC. | 2002-08-27 | — | — | US | disclosed |